Research in Clinical Practice

Gastrointestinal Endoscopy Clinics of North America

Volumn 16, Issue 4, 2006, Pages 751-773

  Schmitt, Colleen M ^a,b  

^a Southeastern Clinical Research   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCOUNTING; CLINICAL PRACTICE; CLINICAL RESEARCH; COMMERCIAL PHENOMENA; COMPETITION; DEVELOPMENT; LAW SUIT; LEISURE; MEDICAL RESEARCH; PERSONNEL; PHYSICIAN; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TRAINING; UNITED STATES;

BIOMEDICAL RESEARCH; BUDGETS; CLINICAL MEDICINE; CLINICAL TRIALS; HUMANS; PATIENT SELECTION; RESEARCH PERSONNEL; RESEARCH SUPPORT; UNITED STATES;

EID: 33750743443     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2006.08.013     Document Type: Review

References (57)

1. Harris Interactive. Most physicians do not participate in clinical trials because of lack of opportunity, time, personnel support and resources. Available at: http://www.harrisinteractive.com/news/mediacoverage.asp. Accessed December 15, 2005.
2. Yuval R., Uziel K., Gordon N., et al. Perceived benefit after participating in positive or negative/neutral heart failure trials: the patients' perspective. Eur J Heart Fail 3 2 (2001) 217-223
3. Madsen S.M., Holm S., Davidsen B., et al. Ethical aspects of clinical trials: the attitudes of participants in two non-cancer trials. J Intern Med 248 6 (2000) 463-474
4. Trauth J.M., Musa D., Siminoff L., et al. Public attitudes regarding willingness to participate in medical research studies. J Health Soc Policy 12 2 (2000) 23-43
5. Pharmaceutical Research and Manufacturers of America. Pharmaceutical industry profile 2005. Available at: http://www.phrma.org/publications/publications//2005-03-17.1143.pdf. Accessed December 15, 2005.
6. Johanson J.F., Overhold B.F., and Frakes J.T. Characteristics of best gastroenterology practices. Am J Gastroenterol 94 9 (1999) 2519-2530
7. Lader E.W., Cannon C.P., Ohman E.M., et al. The clinician as investigator. Participating in clinical trials in the practice setting. Circulation 109 (2004) 2672-2679
8. Neur A. The rising tide of CRC workload and turnover. The CenterWatch Monthly 9 8 (2002) 1-5
9. FDA U.S. Food and Drug Administration. Available at: ==http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=312&showFR=1. Accessed October 15, 2006.
10. Sherman J.W., and Watkins W.D. New DIA program: Clinical investigator education, training, and certification. Drug Inf J 37 (2003) 257-258
11. Schmitt C.M. Establishing a clinical research practice. J Clin Gastroenterol 31 3 (2000) 205-212
12. Jackson M., Berman N., Huber M., et al. Research staff turnover and participant adherence in the Women's Health Initiative. Control Clin Trials 24 4 (2003) 422-435
13. Schmitt C.M. Clinical research. Gastrointest Endosc Clin N Am 12 2 (2002) 395-419
14. American Society of Clinical Oncology policy statement: oversight of clinical research. J Clin Oncol 2003 1521(12):2377-86.
15. Sung N.S., Crowley Jr. W.F., Genel M., et al. Central challenges facing the national clinical research enterprise. JAMA 289 (2003) 1278-1287
16. Rutan R.L., Deitch E.A., and Waymack J.P. Academic surgeons' knowledge of Food and Drug Administration regulations for clinical trials. Arch Surg 132 1 (1997) 94-98
17. Institute of Medicine Clinical Research Roundtable. Developing the clinical investigator workforce: Clinical Research Roundtable Symposium I (2001), National Academy Press, Washington, DC
18. Angell M. 'Abolitionist' Angell calls for clinical trial reform. The NIH Record. July 24, 2001;L111(15).
19. CenterWatch Clinical Trials Listing Service. Available at: http://www.centerwatch.com/professional/site_info.html. Accessed October 15, 2006.
20. Henderson L., Assessing change in CRO usage practices. The CenterWatch Monthly 8(1):1-9.
21. Duke Clinical Research Institute Investigator Info. Available at: http://www.dcri.duke.edu/investigator/index.jsp. Accessed October 15, 2006.
22. The Cystic Fibrosis Foundation. Available at: http://www.cff.org/home.
23. Borfitz D. A turning point for SMOs. The CenterWatch Monthly 11 9 (2004) 1-13
24. Donato B.J., and Gibson T.R. Does your clinical investigator understand the consequences of non-compliance?. Qual Assur 7 3 (1999) 135-145
25. Litchfield J., Freeman J., Schou H., et al. Is the future for clinical trials internet-based? A cluster randomized clinical trial. Clin Trials 2 1 (2005) 72-79
26. Maggon K. Investigator and site selection and performing GCP clinical studies in India. Control Clin Trials 25 4 (2004) 366-377
27. Gullo K, ed. Harris Interactive Healthcare News. Participation in clinical trials lower in Europe and India than in the United States. 2005;5(7):1-15.
28. Paller M.S., Hostetler L., and Dykhuis D.A. Clinical trials at AHCs: the perspective of an academic clinical trials office. Acad Med 77 12 Pt 1 (2002) 1201-1206
29. Beal K., Dean J., Chen J., et al. Budget negotiation for industry-sponsored clinical trials. Anesth Analg 99 1 (2004) 173-176
30. Griffith A.H. Mastering a research contract. In: Programs of the 6th Annual GCP Conference, Clinical Research Nuts and Bolts. Chattanooga (TN): 2005, track B, section 2, p. 3-7.
31. Mello M.M., Studdert D.M., and Brennan T.A. The rise of litigation in human subjects research. Ann Intern Med 139 1 (2003) 40-45
32. Steinbrook R. Biomedical research and biosecurity. N Engl J Med 352 21 (2005) 2212-2214
33. Sox H. Clinical trials registries. Institute of Medicine. Board on Health Sciences Policy. Clinical Trial Registry Workshop. The National Academy of Sciences, Washington DC. June 27, 2005. Available at: http://www.iom.edu/CMS/3740/26703/27457.aspx. Accessed January 20, 2006.
34. Drazen J.M., and Wood A.J. Trial registration report card. N Engl J Med 353 26 (2005) 2809-2811
35. Zarin D.A., Tse T., and Ide N.C. Trial registration at clinicaltrials.gov between May and October 2005. N Engl J Med 353 26 (2005) 2779-2787
36. Sherman. Silverstein, Kohl, Rose and Podolsky Law Offices. Clinical trials litigation. Available at: www.sskrplaw.com. Accessed December 15, 2005.
37. Lifton D.E. Clinical trials: strategies for sponsor manufacturers to minimize the risk of litigation. Gibbons publications. Available at: =http://www.gibbonslaw.com/publications/articlesuser2.cfm?pubid=853. Accessed January 31, 2006.
38. Kernke versus The Menninger Clinic Inc. 173 F. Supp 2d 1117, 1121 (D. Kan. 2001). US District Court for the District of Kansas, Case No. 00-22630GTV.
39. U.S. Department of Health and Human Services. National Institutes of Health. HIPAA Privacy Rule. Available at: http://privacyruleandresearch.nih.gov/clin_research.asp. Accessed October 15, 2006.
40. Morin K., Rakatansky H., Riddick Jr. F.A., et al. Managing conflict of interest in the conduct of clinical trials. JAMA 287 1 (2002) 78-84
41. US Food and Drug Administration. Guidance. Financial disclosure by clinical investigators. Available at: http://www.fda.gov/oc/guidance/financialdis.html. Accessed on December 21, 2005.
42. Angell M. Is academic medicine for sale?. N Engl J Med 342 20 (2000) 1516-1518
43. Glass H.E. Do clinical grant payment practices in phase 3 clinical trials influence subsequent clinical investigator prescribing behavior?. Dis Manage 7 1 (2004) 77-87
44. Ellis P.M. Attitudes towards and participation in randomized clinical trials in oncology: a review of the literature. Ann Oncol 11 8 (2000) 939-945
45. Harris Interactive. Public perception of opportunity to participate in clinical trials has decreased. Available at: ====http://www.marketresearchworld.net/index.php?option=content&task=view&id=83&Itemid=. Accesed January 31, 2006.
46. Association of Clinical Research Professionals. Increasing public awareness of clinical research. The Monitor 18 3 (2004) 39-41
47. International Air Transport Association. Dangerous Goods Regulations. Section 1.5 Training. Available at: http://www.iata.org/NR/ContentConnector/CS2000/SiteInterface/sites/whatwedo/dangerousgoods/file/Section_1.5.pdf. Accessed December 21, 2005.
48. Emanuel E.J., Wood A., Fleischman A., et al. Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med 141 4 (2004) 282-291
49. Rettig R.A. The industrialization of clinical research. Health Aff (Millwood) 19 6 (2000) 129-146
50. Isidor J.M., and Kaltman S.P. Fast track to disaster? Considerations raised by current recruitment techniques for clinical research subjects. J Biolaw Bus 5 3 (2002) 46-47
51. Chen D.T., Miller F.G., and Rosenstein D.L. Clinical research and the physician-patient relationship. Ann Intern Med 138 8 (2003) 669-672
52. Bryant J., and Powell J. Payment to healthcare professionals for patient recruitment to trials: a systematic review. BMJ 331 (2005) 1377-1378
53. Getz K.A. Have we pushed our PIs too far?. Appl Clin Trials (2005)
54. Tuft Center for the Study of Drug Development Impact Report. Number of active investigators in FDA-regulated trials drop. 2005;7(3).
55. Goldfarb N. A win-win solution to the study budget problem. The Monitor 18 4 (2004) 39-40
56. Getz KA. A swift predominance of ex-US sites. Appl Clin Trials 2005.
57. Harris Interactive. Participation in clinical trials lower in Europe and India than in the United States. Available at: ====http://www.marketresearchworld.net/index.php?option=content&task=view&id=87&Itemid=. Accessed January 31, 2006.